Search
From Date :
To Date :
Serivce :
Query :
Keywords :
 ( Seprate With , )
Immunotherapy keeps some advanced head and neck cancer patients alive for over 3 years
A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with some living for three years or more, a major new clinical trial reports.
Cancer immunotherapy uses melanin against melanoma
Researchers have developed a melanin-enhanced cancer immunotherapy technique that can also serve as a vaccine, based on early experiments done in a mouse model. The technique is applied via a transdermal patch.
DNA mutations in blood predict response to immunotherapy
In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.
Scientists develop new immunotherapy for prostate cancer
Researchers at The Wistar Institute have created a new immunotherapy technology to treat prostate cancer using synthetic DNA against a cancer specific protein.
Discovery could guide immunotherapy for lung cancer
Immunotherapy is a type of cancer treatment that boosts the body's natural defenses to fight the cancer.
Study finds immunotherapy against bee stings incomplete
A new study by the German Research Center for Environmental Health has found that immunotherapy against bee stings may be incomplete in some cases.
Immunotherapy slow, but effective, against hay fever
Immunotherapy — often in the form of allergy shots — can combat the runny nose, itchy eyes, congestion, sneezing and sinus pressure of persistent hay fever. But it can't be done in less than three years, British researchers report.
Immunotherapy treatments may better treat skin cancer
Treating one of the most common and deadly forms of skin cancer with a combination of immunotherapy options may improve survival and lower the risk of life-threatening events in the patients diagnosed in the late stages, a new study has found.
Cancer immunotherapy drug may be useful against HIV
A method of reprogramming immune cells to attack cancer may also work to help the body effectively fight off HIV, according to early research.
Quarter of lung cancer patients ineligible for immunotherapy
Lung cancer patients who also have autoimmune diseases are not eligible for the latest immunotherapy treatments, according to a team of researchers from the University of Texas Southwestern Medical Center.
Discovery opens door to new strategy for cancer immunotherapy
In a study, an international collaboration of investigators from Dana-Farber, Harvard Medical School, Boston Children's Hospital, and the University of Strasbourg uncovered a mechanism that allows key immune system cells to keep a steady rein on their more belligerent brother cells, thereby protecting normal, healthy tissue from assault. The discovery has powerful implications for cancer immunotherapy researchers say: By blocking the mechanism with a drug, it may be possible to turn the attack-suppressing cells into tumor-attacking cells.
Promising developments in tackling resistance to blood cancer drugs
A drug with the potential to reverse resistance to immunotherapy has been developed by scientists at the University of Southampton. It has shown great promise in pre-clinical models and will be available to patients with certain leukemias and non-Hodgkin lymphomas in clinical trials later this year.
Immunotherapy a breakthrough in bladder cancer treatment
A study that shows how an antibody drug can make it easier for the immune system to find and destroy cancer cells is hailed as a breakthrough in advanced bladder cancer treatment.

Page Generated in 2/0922 sec